Carregant...
Phospholipase D1 is upregulated by vorinostat and confers resistance to vorinostat in glioblastoma
Glioblastoma (GBM) is an aggressive brain tumor and drug resistance remains a major barrier for therapeutics. Epigenetic alterations are implicated in GBM pathogenesis, and epigenetic modulators including histone deacetylase (HDAC) inhibitors are exploited as promising anticancer therapies. Here, we...
Guardat en:
| Publicat a: | J Cell Physiol |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley and Sons Inc.
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7692931/ https://ncbi.nlm.nih.gov/pubmed/32869317 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcp.29882 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|